D. Nagel
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 7
- Lung Cancer Research Studies 4
- Cancer Diagnosis and Treatment 2
- Peptidase Inhibition and Analysis 2
-
- Radiopharmaceutical Chemistry and Applications 4
- Co-authors
- P Stieber (18 shared papers)D. Seidel (5 shared papers)Rainer Muche (1 shared paper)A. Fateh‐Moghadam (5 shared papers)Harald Elster (1 shared paper)Horst Mann (1 shared paper)Barbara Labrot (1 shared paper)Peter Cremer (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Cancer (3 papers)Clinical Endocrinology (1 paper)European Journal of Clinical Investigation (1 paper)Annals of Oncology (1 paper)
- Partner nations
- Germany
In The Last Decade
D. Nagel
24 papers receiving 963 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 238
- Oncology 281
- Endocrinology, Diabetes and Metabolism 121
- Pulmonary and Respiratory Medicine 174
- Surgery 217
Countries citing papers authored by D. Nagel
This map shows the geographic impact of D. Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Nagel more than expected).
Fields of papers citing papers by D. Nagel
This network shows the impact of papers produced by D. Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Nagel. The network helps show where D. Nagel may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Nagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 261 | |
| 2 | 2002 | 170 | |
| 3 | 2018 | 120 | |
| 4 | Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. | 2001 | 113 |
| 5 | 2015 | 65 | |
| 6 | 1991 | 64 | |
| 7 | 2013 | 46 | |
| 8 | Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. | 1997 | 39 |
| 9 | Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis. | 1999 | 32 |
| 10 | Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma. | 1997 | 26 |
| 11 | Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases. | 1998 | 14 |
| 12 | 2011 | 9 | |
| 13 | 2004 | 7 | |
| 14 | 2006 | 6 | |
| 15 | 2009 | 6 | |
| 16 | 1996 | 6 | |
| 17 | 1997 | 4 | |
| 18 | 2008 | 4 | |
| 19 | 1994 | 4 | |
| 20 | 1985 | 3 |
About D. Nagel
D. Nagel is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Research Studies (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Diagnosis and Treatment (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (238 citations), Oncology (281 citations), Endocrinology, Diabetes and Metabolism (121 citations), Pulmonary and Respiratory Medicine (174 citations) and Surgery (217 citations). D. Nagel has collaborated with scholars based in Germany. Frequent co-authors include P Stieber, D. Seidel, Rainer Muche, A. Fateh‐Moghadam, Harald Elster, Horst Mann, Barbara Labrot, Peter Cremer, Volker Heinemann and Michael Untch. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Clinical Endocrinology, European Journal of Clinical Investigation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.